يعرض 1 - 10 نتائج من 64 نتيجة بحث عن '"Fabian Hoti"', وقت الاستعلام: 1.09s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    المساهمون: Päijät-Häme Welfare Consortium, HYKS erva

    المصدر: Karasik, A, Lanzinger, S, Chia-Hui Tan, E, Yabe, D, Kim, D J, Sheu, W H H, Melzer-Cohen, C, Holl, R W, Ha, K H, Khunti, K, Zaccardi, F, Subramanian, A, Nirantharakumar, K, Nyström, T, Niskanen, L, Linnemann Jensen, M, Hoti, F, Klement, R, Déruaz-Luyet, A, Kyaw, M H, Koeneman, L, Vistisen, D, Carstensen, B, Halvorsen, S, Langslet, G, Fazeli Farsani, S, Patorno, E, Núñez, J & EMPRISE Europe and Asia Study Group 2023, ' Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia : Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study ', Diabetes and Metabolism, vol. 49, no. 2, 101418 . https://doi.org/10.1016/j.diabet.2022.101418

    وصف الملف: application/pdf

  8. 8
  9. 9
  10. 10

    المصدر: Ehrenstein, V, Huang, K, Kahlert, J, Bahmanyar, S, Karlsson, P, Löfling, L, Nunes, A P, Enger, C, Bezemer, I D, Kuiper, J G, Hoti, F, Juuti, R, Korhonen, P, Mo, J, Schachterle, S E, Wilner, K D, Rørth, M & Sørensen, H T 2021, ' Outcomes in patients with lung cancer treated with crizotinib and erlotinib in routine clinical practice : A post-authorization safety cohort study conducted in Europe and in the United States ', Pharmacoepidemiology and Drug Safety, vol. 30, no. 6, pp. 758-769 . https://doi.org/10.1002/pds.5193

    وصف الملف: application/pdf